• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中文版:脑卒中患者中加入认知维度的 EQ-5D-5L 量表的有效性。

Validity of an enhanced EQ-5D-5L measure with an added cognitive dimension in patients with stroke.

机构信息

Center of Excellence for Rehabilitation Medicine and UMC Utrecht Brain Center, University Medical Center Utrecht and De Hoogstraat Rehabilitation, Utrecht University, Utrecht, The Netherlands.

Department of Rehabilitation, Physical Therapy Science & Sports, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

出版信息

Clin Rehabil. 2020 Apr;34(4):545-550. doi: 10.1177/0269215520907990. Epub 2020 Feb 19.

DOI:10.1177/0269215520907990
PMID:32070131
Abstract

OBJECTIVE

The 5-level EuroQoL (EQ-5D-5L) is a patient-reported outcome measure frequently used in stroke research. However, it does not assess the cognitive problems many patients with stroke experience. The aim of this article is to compare the content validity, internal consistency and discriminative ability of the EQ-5D-5L with and without an additional cognitive domain (EQ-5D-5L+C), administered three months post-stroke.

DESIGN

Cross-sectional study.

SETTING

Six general hospitals in the Netherlands.

SUBJECTS

In all, 360 individuals with stroke three months after the event.

INTERVENTIONS

Not applicable.

MAIN MEASURES

The modified Rankin Scale and EQ-5D-5L+C were administered in telephone interviews three months post-stroke.

RESULTS

A total of 360 patients with stroke were included. Mean age was 68.8 years (standard deviation (SD) = 11.7), 143 (40%) were female, 334 (93%) had had an ischemic stroke, 165 (46%) had a National Institutes of Health Stroke Scale (NIHSS) score ⩽ 4 at presentation and the Barthel Index was 17.2 (SD = 4) four days post-stroke. Cognitive problems were reported by 199 (55%) patients three months post-stroke. Internal consistencies of the EQ-5D-5L and EQ-5D-5L+C were 0.75 and 0.77, respectively. Adding a cognitive domain resulted in a decrease of the ceiling effect from 22% to 14%. Both EQ-5D-5L and EQ-5D-5L+C showed good discriminative ability, but differences between patients with different modified Rankin Scale scores and with/without reported decrease in health and daily activities were slightly larger with the EQ-5D-5L+C compared to the EQ-5D-5L.

CONCLUSIONS

The EQ-5D-5L+C, which includes a cognitive domain that is highly significant for stroke patients, showed increased content validity and good discriminative ability, without losing internal consistency.

摘要

目的

欧洲五维健康量表(EQ-5D-5L)是一种常用于中风研究的患者报告结局测量工具。然而,它并未评估许多中风患者经历的认知问题。本文旨在比较中风后 3 个月时使用和不使用额外认知域的 EQ-5D-5L(EQ-5D-5L+C)的内容效度、内部一致性和区分能力。

设计

横断面研究。

地点

荷兰的 6 家综合医院。

受试者

共 360 名中风后 3 个月的个体。

干预措施

无。

主要观察指标

中风后 3 个月通过电话访谈进行改良 Rankin 量表和 EQ-5D-5L+C 评估。

结果

共纳入 360 例中风患者。平均年龄为 68.8 岁(标准差[SD] = 11.7),143 例(40%)为女性,334 例(93%)为缺血性中风,165 例(46%)发病时 NIHSS 评分 ⩽ 4,Barthel 指数为 4 天发病后 17.2(SD = 4)。3 个月后,199 例(55%)患者报告存在认知问题。EQ-5D-5L 和 EQ-5D-5L+C 的内部一致性分别为 0.75 和 0.77。增加认知域可将天花板效应从 22%降低至 14%。EQ-5D-5L 和 EQ-5D-5L+C 均具有良好的区分能力,但与 EQ-5D-5L 相比,EQ-5D-5L+C 用于评估不同改良 Rankin 量表评分和报告健康和日常活动下降的患者时,差异略大。

结论

包含对中风患者非常重要的认知域的 EQ-5D-5L+C 具有更高的内容效度和良好的区分能力,同时不丧失内部一致性。

相似文献

1
Validity of an enhanced EQ-5D-5L measure with an added cognitive dimension in patients with stroke.中文版:脑卒中患者中加入认知维度的 EQ-5D-5L 量表的有效性。
Clin Rehabil. 2020 Apr;34(4):545-550. doi: 10.1177/0269215520907990. Epub 2020 Feb 19.
2
Comparison between EQ-5D-5L and PROMIS-10 to evaluate health-related quality of life 3 months after stroke: a cross-sectional multicenter study.EQ-5D-5L 与 PROMIS-10 在评估卒中后 3 个月健康相关生活质量的比较:一项横断面多中心研究。
Eur J Phys Rehabil Med. 2021 Jun;57(3):337-346. doi: 10.23736/S1973-9087.21.06335-8. Epub 2021 Jan 15.
3
Comparing the EQ-5D-5L and stroke impact scale 2.0 in stroke patients: an analysis of measurement properties.比较中风患者的 EQ-5D-5L 和中风影响量表 2.0:测量特性分析。
Health Qual Life Outcomes. 2024 Jun 5;22(1):45. doi: 10.1186/s12955-024-02252-z.
4
Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients.比较EQ-5D-5L、EQ-5D-3L和EQ视觉模拟量表在中风患者中的反应性。
Qual Life Res. 2015 Jun;24(6):1555-63. doi: 10.1007/s11136-014-0873-7. Epub 2014 Nov 26.
5
EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.欧洲五维度健康量表(EQ-5D-5L)在评估成人哮喘患者生活质量中的效度:横断面研究
J Med Internet Res. 2019 Jan 23;21(1):e10178. doi: 10.2196/10178.
6
The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.在测量等待全髋关节置换术或全膝关节置换术的患者的健康相关生活质量方面,EQ-5D-5L 优于 -3L 版本。
Clin Orthop Relat Res. 2019 Jul;477(7):1632-1644. doi: 10.1097/CORR.0000000000000662.
7
The added value of extending the EQ-5D-5L with an itching item for the assessment of health-related quality of life of burn patients: an explorative study.增加一个瘙痒项目评估烧伤患者健康相关生活质量的 EQ-5D-5L 的附加价值:一项探索性研究。
Burns. 2021 Jun;47(4):873-879. doi: 10.1016/j.burns.2020.08.015. Epub 2020 Sep 12.
8
Validity of EQ-5D-5L in stroke.EQ-5D-5L在中风中的有效性。
Qual Life Res. 2015 Apr;24(4):845-50. doi: 10.1007/s11136-014-0834-1. Epub 2014 Oct 28.
9
Psychometric Properties of EQ-5D-3L and EQ-5D-5L in Cognitively Impaired Patients Living with Dementia.认知障碍的痴呆患者中 EQ-5D-3L 和 EQ-5D-5L 的心理测量特性。
J Alzheimers Dis. 2021;83(1):77-87. doi: 10.3233/JAD-210421.
10
Testing the Psychometric Properties of 9 Bolt-Ons for the EQ-5D-5L in a General Population Sample.在一般人群样本中测试 EQ-5D-5L 的 9 个附加模块的心理测量特性。
Value Health. 2024 Jul;27(7):943-954. doi: 10.1016/j.jval.2024.03.2195. Epub 2024 Apr 9.

引用本文的文献

1
Feasibility of implementing a codesigned patient reported outcome measures (PROMs) collection system for older adults in acute and sub-acute hospital settings.在急性和亚急性医院环境中为老年人实施联合设计的患者报告结局测量(PROMs)收集系统的可行性。
Qual Life Res. 2025 Feb 28. doi: 10.1007/s11136-025-03931-0.
2
Testing the psychometric characteristics of EQ-5D-5L and respiratory bolt-ons using a sample of the Australian population.使用澳大利亚人群样本测试EQ-5D-5L及呼吸附加模块的心理测量特性。
Qual Life Res. 2025 Feb;34(2):395-403. doi: 10.1007/s11136-024-03817-7. Epub 2024 Oct 26.
3
The added value of the cognition, dining, gastrointestinal problems, sleep and tiredness bolt-on dimensions to the EQ-5D-5L in patients with coeliac disease.
乳糜泻患者中认知、饮食、胃肠道问题、睡眠和疲劳附加维度对EQ-5D-5L的附加值。
Eur J Health Econ. 2025 Apr;26(3):473-485. doi: 10.1007/s10198-024-01719-6. Epub 2024 Aug 30.
4
Testing four cognition bolt-on items to the EQ-5D in a general Chinese population.在中国普通人群中对EQ-5D测试四个认知附加项目。
Eur J Health Econ. 2025 Apr;26(3):403-411. doi: 10.1007/s10198-024-01714-x. Epub 2024 Aug 9.
5
Enhancing EQ-5D-5L Sensitivity in Capturing the Most Common Symptoms in Post-COVID-19 Patients: An Exploratory Cross-Sectional Study with a Focus on Fatigue, Memory/Concentration Problems and Dyspnea Dimensions.提高 EQ-5D-5L 在捕捉新冠后患者最常见症状方面的灵敏度:一项关注疲劳、记忆/注意力问题和呼吸困难维度的探索性横断面研究。
Int J Environ Res Public Health. 2024 May 3;21(5):591. doi: 10.3390/ijerph21050591.
6
Health state utility estimates for value assessments of novel treatments in Huntington's disease: a systematic literature review.用于亨廷顿病新型治疗方法价值评估的健康状态效用估计值:系统文献回顾。
Health Qual Life Outcomes. 2024 Apr 16;22(1):33. doi: 10.1186/s12955-024-02242-1.
7
Healthcare consumer acceptability of routine use of the EQ-5D-5L in clinical care: a cross-sectional survey.医疗保健消费者对在临床护理中常规使用EQ-5D-5L的可接受性:一项横断面调查。
Qual Life Res. 2024 May;33(5):1307-1321. doi: 10.1007/s11136-024-03598-z. Epub 2024 Feb 7.
8
Acceptability of the routine use and collection of a generic patient reported outcome measure from the perspective of healthcare staff: a qualitative study.从医护人员的角度出发,评估常规使用和收集通用患者报告结局测量指标的可接受性:一项定性研究。
J Patient Rep Outcomes. 2023 Jul 31;7(1):81. doi: 10.1186/s41687-023-00617-4.
9
Health State Utility Values in People With Stroke: A Systematic Review and Meta-Analysis.脑卒中患者的健康状态效用值:系统评价和荟萃分析。
J Am Heart Assoc. 2022 Jul 5;11(13):e024296. doi: 10.1161/JAHA.121.024296. Epub 2022 Jun 22.
10
Randomised placebo-controlled multicentre trial to evaluate the efficacy and safety of JTR-161, allogeneic human dental pulp stem cells, in patients with Acute Ischaemic stRoke (J-REPAIR).随机安慰剂对照多中心试验,评估 JTR-161(同种异体人牙髓干细胞)治疗急性缺血性脑卒中患者的疗效和安全性(J-REPAIR)。
BMJ Open. 2022 May 24;12(5):e054269. doi: 10.1136/bmjopen-2021-054269.